At the Competition and Markets Authority, Nanret obtained litigation experience in the following areas:
• Appeals of CA98 decisions on pharmaceutical drugs: advised on multi-party CA98 appeals and worked on complex confidentiality reviews in support of these cases. Experience includes the Phenytoin appeals (CMA v Flynn Pharma and Pfizer) before the Court of Appeal and Liothyronine appeals (Hg Capital, Cinven S.A.R.L, Mercury Pharmaceuticals) before the Competition Appeal Tribunal.
• Market studies and investigations: advised on the statutory appeals of the CMA’s market investigation on mobile radio network services, and the CMA’s decision to launch a market investigation on mobile browsers and cloud gaming in the UK.
• Merger investigations: part of the legal team considering the Meta/Giphy Phase 2 merger inquiry and heavily involved in advising on Meta’s challenge to the merger decision heard by the Competition Appeal Tribunal.
• Administrative penalties: advised on two administrative penalties imposed on Meta Platforms, Inc in relation to failures to comply with an interim enforcement order (IEO). The penalties (£50.5 million and £1.5 million respectively) were the highest and third highest IEO administrative penalties ever issued by the CMA at that time.
At Hausfeld, Nanret is part of the automotive team working with our clients on cartel damages actions.
